Nutriflex Omega (Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonin)

Nutriflex Omega is an amino acid mixture used in parenteral nutrition to address protein and nitrogen requirements in several clinical situations.

• Critical illness: helps meet increased protein needs and supports tissue repair.
• Post‑operative recovery: provides essential amino acids for wound healing and muscle preservation.
• Severe malnutrition: supplies a balanced amino acid profile when oral intake is insufficient.
• Burn injuries: contributes to the high protein turnover required for skin regeneration.
• Long‑term total parenteral nutrition (TPN): maintains nitrogen balance in patients dependent on intravenous feeding.

• The amino acids in Nutriflex Omega are directly incorporated into the body's protein synthesis pathways. By supplying essential and non‑essential amino acids, the formulation replenishes nitrogen stores, supports gluconeogenesis, and facilitates the production of neurotransmitters and immune mediators, thereby sustaining metabolic homeostasis during periods of inadequate oral intake.

Adverse reactions to Nutriflex Omega are generally related to the intravenous route and the composition of the solution.

Common Side Effects

• Mild fever or chills during infusion.
• Transient elevation of liver enzymes.
• Electrolyte disturbances (e.g., mild hypernatremia).
• Local irritation at the infusion site.
• Nausea or vomiting.

Serious or Rare Side Effects

• Anaphylactic or severe hypersensitivity reactions.
• Hyperosmolar metabolic acidosis.
• Thrombophlebitis or catheter‑related bloodstream infection.
• Severe electrolyte imbalance (e.g., hyperkalemia, hyperphosphatemia).
• Renal impairment or acute kidney injury.

Nutriflex Omega should be administered under close clinical supervision, with attention to patient‑specific factors and laboratory monitoring.

• Renal function: assess baseline creatinine and adjust infusion rate if impaired.
• Hepatic function: monitor liver enzymes, especially in patients with pre‑existing liver disease.
• Electrolyte balance: check serum electrolytes before and during therapy.
• Infusion rate: use recommended flow rates to avoid osmotic overload.
• Compatibility: verify compatibility with other intravenous medications before co‑administration.
• Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Nutriflex Omega may interact with other intravenously administered agents, requiring careful coordination.

Major Interactions (Avoid)

• Concurrent high‑dose potassium chloride: risk of severe hyperkalemia.
• Acidifying solutions (e.g., sodium bicarbonate) mixed directly: can cause precipitation.

Moderate Interactions (Monitor Closely)

• Loop diuretics: may exacerbate electrolyte shifts.
• Insulin therapy: amino acids can stimulate insulin release, affecting glucose control.
• Other parenteral nutrition components: ensure total nitrogen and caloric load remain within prescribed limits.
• Anticoagulants: monitor coagulation parameters if central lines are used.
• Vasopressors: observe for changes in hemodynamic response during infusion.